Navidea Biopharmaceuticals

Navidea Biopharmaceuticals is a leader in precision medicine with immuno-targeted products designed to help identify the sites.

Navidea Biopharmaceuticals, Inc. (NYSE MKT: NAVB) is a leader in precision medicine with immuno-targeted products designed to help identify the sites and pathways of undetected disease and enable better diagnostic accuracy, clinical decision-making, targeted treatment and, ultimately, patient care. The Company focuses on the development of innovative immunodiagnostic agents and immunotherapeutics that can and will make a difference for individuals, as well as their families, physicians and care givers, touched by devastating conditions like cancer, autoimmune, infectious and inflammatory diseases. For patients and physicians, they aspire to provide innovative immunodiagnostic agents and therapies to improve patient care for serious diseases. For investors, they aim to deliver superior growth through their focus developing their innovative Manocept platform and driving efficient business processes. For their employees, They provide a culture that focuses on the direct contributions their efforts make for the patients they serve and an innovative development environment for new breakthrough products.